All Stories

  1. Muscle atonia index during multiple sleep latency test: A possible marker to differentiate narcolepsy from other hypersomnias
  2. Interictal and subclinical ictal discharges emerging from tonic REM sleep in sleep-related hypermotor epilepsy
  3. Sleep macrostructure and cyclic alternating pattern in patients who underwent surgery for hippocampal sclerosis: A prospective controlled polysomnographic study
  4. Editorial: Epilepsy in older adults: From physiopathology to improvements in diagnosis and management
  5. Effects of Transcranial Direct Current Stimulation on Sleep in Athletes: A Protocol of a Randomized Controlled Trial
  6. Residual excessive daytime sleepiness (EDS) in Italian patients with obstructive sleep apnea (OSA) treated with continuous positive airway pressure (CPAP): preliminary results of the OSAREDS study
  7. Editorial: Effects of COVID-19 on sleep and circadian rhythms: Searching for evidence of reciprocal interactions
  8. Deprescribing antihypertensive drugs after starting OSA primary therapy: “first do no net harm?”
  9. Clinical characteristics of a large cohort of patients with narcolepsy candidate for pitolisant: a cross-sectional study from the Italian PASS Wakix® Cohort
  10. Questionnaire-based assessment of sleep disorders in an adult population of Tuberous Sclerosis Complex
  11. Sleep Disorders in Patients With Craniopharyngioma: A Physiopathological and Practical Update
  12. The actigraphic documentation of circadian sleep-wake rhythm dysregulation in myotonic dystrophy type 1
  13. The impact of antiseizure medications on polysomnographic parameters: a systematic review and meta-analysis
  14. Subjective sleep disorders and daytime sleepiness in patients with restrictive type anorexia nervosa and effects on quality of life: a case–control study
  15. Expert Opinion: Managing sleep disturbances in people with epilepsy
  16. Cognitive decline in late-onset epilepsy of undefined etiology: A longitudinal cohort study
  17. Levetiracetam, lamotrigine and carbamazepine: which monotherapy during pregnancy?
  18. Guía clínica para el diagnóstico y seguimiento de la distrofia miotónica tipo 1, DM1 o enfermedad de Steinert: somnolencia y papel de la escala de somnolencia de Epworth
  19. Narcolepsy type 1 features across the life span: age impact on clinical and polysomnographic phenotype
  20. Appropriate use of generic and branded antiseizure medications in epilepsy: Updated recommendations from the Italian League Against Epilepsy (LICE)
  21. Subjective sleep disorders and daytime sleepiness in patients with restrictive type anorexia nervosa and effects on quality of life: a case-control study.
  22. Effects of eslicarbazepine as add-on therapy on sleep architecture in temporal lobe epilepsy: results from “Esleep” study
  23. Deprescribing in epilepsy: “First do no net harm”
  24. Pharmacokinetic considerations about antiseizure medications in the elderly
  25. Heart Rate Variability Parameters During Psychogenic Non-epileptic Seizures: Comparison Between Patients With Pure PNES and Comorbid Epilepsy
  26. The efficacy of perampanel as adjunctive therapy in drug-resistant focal epilepsy in a “real world” context: focus on temporal lobe epilepsy
  27. Epilepsy Care in the Time of COVID-19 Pandemic in Italy: Risk Factors for Seizure Worsening
  28. A false alarm of narcolepsy: obstructive sleep apnea masquerading as narcolepsy and vice-versa: two further controversial cases
  29. Determination of Perampanel in Dried Plasma Spots: Applicability to Therapeutic Drug Monitoring
  30. CSF levels of the endocannabinoid anandamide are reduced in patients with untreated narcolepsy type 1: a pilot study
  31. Dysregulation Of beta-amyloid metabolism in narcolepsy
  32. Excessive daytime sleepiness and fatigue in neurological disorders
  33. Dream Recall and Content versus the Menstrual Cycle: A Cross-Sectional Study in Healthy Women
  34. Sleep Complaints, Sleep and Breathing Disorders in Myotonic Dystrophy Type 2
  35. Alzheimer's disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathology
  36. Comparative Sleep Disturbances in Myotonic Dystrophy Types 1 and 2
  37. Insight into epileptic and physiological déjà vu : from a multicentric cohort study
  38. Profile of pitolisant in the management of narcolepsy: design, development, and place in therapy
  39. Restless legs syndrome is highly prevalent in patients with postpolio syndrome
  40. Complement system dysregulation in patients affected by Idiopathic Generalized Epilepsy and the effect of antiepileptic treatment
  41. Posterior Reversible Encephalopathy Syndrome after Hematopoietic Cell Transplantation in Children with Hemoglobinopathies
  42. Validation Study of Italian Version of Inventory for Déjà Vu Experiences Assessment (I-IDEA): A Screening Tool to Detect Déjà Vu Phenomenon in Italian Healthy Individuals
  43. Validation Study of Italian Version of Inventory for DéJà vu Experiences Assessment (I-IDEA): A Screening Tool to Detect DéJà vu Phenomenon in Italian Healthy Individuals
  44. Effects of adjunctive perampanel on sleep quality, daytime somnolence and cognition in refractory focal epilepsy: further data.
  45. Obstructive Sleep Apnea is Associated With Early but Possibly Modifiable Alzheimer’s Disease Biomarkers Changes
  46. Cardiac Autonomic Changes in Epilepsy
  47. Vitamin D status of male OSAS patients improved after long-term CPAP treatment mainly in obese subjects
  48. Epilepsy, amyloid-β, and D1 dopamine receptors: a possible pathogenetic link?
  49. Predicting seizures in untreated temporal lobe epilepsy using point-process nonlinear models of heartbeat dynamics
  50. Rapid eye movement sleep disruption and sleep fragmentation are associated with increased orexin-A cerebrospinal-fluid levels in mild cognitive impairment due to Alzheimer's disease
  51. Heart rate variability in untreated newly diagnosed temporal lobe epilepsy: Evidence for ictal sympathetic dysregulation
  52. Beta-amyloid and phosphorylated tau metabolism changes in narcolepsy over time
  53. Obstructive sleep apnoea as a risk factor for osteopenia and osteoporosis in the male population
  54. Optic Nerve Dysfunction in Obstructive Sleep Apnea: An Electrophysiological Study
  55. Estrogen Deficiency Hampers the Beneficial Effect of Continuous Positive Airway Pressure Therapy on Serum Vitamin D Concentrations in Postmenopausal Women Affected by Obstructive Sleep Apnea
  56. Effective treatment of nocturnal frontal lobe epilepsy with lacosamide: a report of two cases
  57. Erratum
  58. Chronic dopaminergic treatment in restless legs syndrome: does it affect the autonomic nervous system?
  59. MicroRNA expression is dysregulated in narcolepsy: a new evidence?
  60. Continuous Positive Airway Pressure Treatment Increases Serum Vitamin D Levels in Male Patients with Obstructive Sleep Apnea
  61. Zonisamide in the management of epilepsy in the elderly
  62. Folic Acid Supplements During Pregnancy in Specific Clinical Settings
  63. Epilepsy surgery in adult-onset Rasmussen’s encephalitis: case series and review of the literature
  64. Evidence of hydrogen sulfide involvement in amyotrophic lateral sclerosis
  65. Nocturnal frontal lobe epilepsy with paroxysmal arousals due to CHRNA2 loss of function
  66. Restless Legs Syndrome and Poliomyelitis: New Evidences of an Old Observation?
  67. Refractory restless legs syndrome remitting after dual kidney transplantation
  68. Acute postoperative seizures and long-term seizure outcome after surgery for hippocampal sclerosis
  69. Oral l-carnitine as treatment for narcolepsy without cataplexy during pregnancy: A case report
  70. Symptomatic nonconvulsive status epilepticus erroneously suggestive of sporadic Creutzfeldt–Jakob disease
  71. Amelioration of Untreated Restless Legs Syndrome by Tadalafil in a Patient With Erectile Dysfunction
  72. Bilateral thalamic stroke due to nasal ephedrine and naphazoline use
  73. Orexinergic System Dysregulation, Sleep Impairment, and Cognitive Decline in Alzheimer Disease
  74. Restless legs syndrome and post polio syndrome: a case−control study
  75. May CSF beta-amyloid and tau proteins levels be influenced by long treatment duration and stable medication in narcolepsy?
  76. Is autonomic nervous system involved in restless legs syndrome during wakefulness?
  77. Multiple sleep latency test may be not sensitive in obstructive sleep apnea with comorbid narcolepsy revealed by low cerebrospinal fluid orexin levels
  78. Cerebrospinal-fluid orexin levels and daytime somnolence in frontotemporal dementia
  79. Restless legs syndrome and daytime sleepiness are prominent in myotonic dystrophy type 2
  80. Can nocturnal groaning be suspected by cardiorespiratory polygraphy?
  81. Circadian Fatigue or Unrecognized Restless Legs Syndrome? The Post-Polio Syndrome Model
  82. Circadian variation of fatigue in paralytic poliomyelitis and postpolio syndrome: just fatigue or masked restless legs syndrome?
  83. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children
  84. Effects of epilepsy treatment on sleep architecture and daytime sleepiness: An evidence-based review of objective sleep metrics
  85. Sleep disorders in spinal and bulbar muscular atrophy (Kennedy’s disease): a controlled polysomnographic and self-reported questionnaires study
  86. CSF beta-amyloid levels are altered in narcolepsy: a link with the inflammatory hypothesis?
  87. Fronto-central monomorphic theta activity as EEG pattern of ictal psychosis
  88. Topiramate-induced periodic limb movement disorder in a patient affected by focal epilepsy
  89. Lacosamide as add-on treatment of focal symptomatic epilepsy in a patient with alcoholic liver cirrhosis
  90. Unexpected total recovery in a patient with post-anoxic complete alpha coma predicted by recording of cortical SEPs
  91. Electrophysiological and amperometric evidence that modafinil blocks the dopamine uptake transporter to induce behavioral activation
  92. Improvement of Restless Legs Syndrome by Varenicline as Antismoking Treatment
  93. Sleep disorders in myotonic dystrophy type 2: a controlled polysomnographic study and self-reported questionnaires
  94. Electroencephalography and Dementia: A Literature Review and Future Perspectives
  95. Paucisymptomatic Marchiafava–Bignami disease with relevant diffusion-weighted MRI lesions
  96. Unilateral spatial neglect and alien limb phenomenon may be early features of Creutzfeldt–Jakob disease
  97. Increased cortical excitability after selective REM sleep deprivation in healthy humans: A transcranial magnetic stimulation study
  98. Effects of zonisamide as add-on therapy on sleep-wake cycle in focal epilepsy: A polysomnographic study
  99. Sleep and Epilepsy
  100. Sleep-Wake Cycle and Daytime Sleepiness in the Myotonic Dystrophies
  101. Spasticity as an ictal pattern due to excitotoxic upper motor neuron damage
  102. Pure ictal sensory seizures may represent a clinical manifestation of PLEDs
  103. Sleep disorders in adult-onset myotonic dystrophy type 1: a controlled polysomnographic study
  104. Cognitive profile and brain morphological changes in obstructive sleep apnea
  105. Non-motor functions in parkinsonian patients implanted in the pedunculopontine nucleus: Focus on sleep and cognitive domains
  106. Late-onset MNGIE without peripheral neuropathy due to incomplete loss of thymidine phosphorylase activity
  107. Cerebrospinal fluid levels of the endocannabinoid anandamide are reduced in patients with untreated newly diagnosed temporal lobe epilepsy
  108. Pregabalin as add-on therapy induces REM sleep enhancement in partial epilepsy: a polysomnographic study
  109. ICTAL Aphasia as Manifestation of Partial Status Epilepticus in a Long-Lasting Misdiagnosed Symptomatic Epilepsy: An Emblematic Case
  110. Effective treatment of narcolepsy–cataplexy with duloxetine: A report of three cases
  111. Oxcarbazepine in Nocturnal Frontal-Lobe Epilepsy: A Further Interesting Report
  112. Sleep-wake cycle and effects of cabergoline monotherapy in de novo Parkinson’s disease patients
  113. Corrigendum
  114. Pedunculopontine nucleus stimulation influences REM sleep in Parkinson’s disease
  115. Cognitive and psychiatric effects of topiramate monotherapy in migraine treatment: an open study
  116. Topiramate-induced restless legs syndrome
  117. Carotid Artery Stenting With Filter Protection in High-Risk Patients Showing Severe Electroencephalographic Alterations During Carotid Endarterectomy
  118. Effect of cabergoline added to levodopa treatment on sleep-wake cycle in idiopathic Parkinson’s disease: an open label 24-hour polysomnographic study
  119. Sleep episodes and daytime somnolence as result of individual susceptibility to different dopaminergic drugs in a PD patient: a polysomnographic study
  120. Baroreflex Buffering of Sympathetic Activation During Sleep: Evidence From Autonomic Assessment of Sleep Macroarchitecture and Microarchitecture
  121. Topiramate: effect on EEG interictal abnormalities and background activity in patients affected by focal epilepsy
  122. Bilateral frontal polymicrogyria and epilepsy in a patient with Turner mosaicism: a case report
  123. Sleep-related changes in baroreflex sensitivity and cardiovascular autonomic modulation
  124. Quantitative EEG and dynamic susceptibility contrast MRI in Alzheimer's disease: a correlative study
  125. QUANTITATIVE EEG PATTERNS FOLLOWING UNILATERAL STROKE: A STUDY IN CHRONIC STAGE
  126. Clinical Case Report: CORTICAL DYSPLASIA, TEMPORAL ATROPHY, MENTAL RETARDATION, DYSMORPHIC FACIES, AND PARTIAL EPILEPSY: AN EEG AND DYNAMIC SUSCEPTIBILITY CONTRAST (DSC) MRI STUDY IN A NEW POSSIBLE GENETIC SYNDROME
  127. Dynamic Susceptibility Contrast (DSC) MRI and Interictal Epileptiform Activity in Cryptogenic Partial Epilepsy
  128. Ketotic hyperglycemia and epilepsia partialis continua
  129. Gabapentin-induced modulation of interictal epileptiform activity related to different vigilance levels
  130. Effect of antiepileptic drugs on sleep
  131. Gabapentin as add-on therapy in focal epilepsy: a computerized EEG study
  132. Changes of the Eeg Paroxysmal Pattern During Felbamate Therapy in Lennox-Gastaut Syndrome: A Case Report